Effectiveness of Dry Needling in Fibromyalgia Patients
Unknown statusNot applicableNCT04942444
View the official record on ClinicalTrials.gov Recruiting status changes often. Contact the study team listed on ClinicalTrials.gov, and talk to your doctor before joining a study.
This study has no listed site in Canada in this snapshot. It is included as part of the worldwide chronic pain corpus.
Brief summary (from the registry)
Patients with fibromyalgia (FM) complain of widespread chronic pain from deep tissues including muscles. Previous research highlights the relevance of impulse input from deep tissues for clinical FM pain. Deep dry needle stimulation is an invasive treatment modality used in the management of musculoskeletal pain. Its efficacy has been confirmed in the management of myofascial trigger points, so the purpose of the study is to determine if blocking abnormal impulse input with deep dry needling stimulation of tender point may decrease hyperalgesia, clinical pain and associated symptoms such as anxiety, depression, fatigue and improve the quality of life in FM patients.
Study details
- Official title
- Dry Needling in Patients With Fibromyalgia: Analysis of Its Therapeutic Effectiveness
- Conditions
- Fibromyalgia
- Chronic Pain
- Anxiety
- Depression
- Fatigue
- Sleep Disorder
- Interventions
- Sponsor
- CEU San Pablo University
- Start date
- 2011-01-10
- Primary completion
- 2011-02-01
- Sex
- All
- Age range
- from 18 Years
- Results posted
- No results posted in this snapshot
- Countries
- Spain
- Total sites listed
- 1
Eligibility criteria
Show eligibility criteria (verbatim from the registry)
Inclusion Criteria: * Patients who had not responded to any of the previously used pharmacological and non-pharmacological treatments. * Literate and able to complete the questionnaires and scales used in the study. * Patients who accepted their inclusion in the trial signed the corresponding informed consent and were given an explanatory sheet of the project. Exclusion Criteria: * Patients with CNS involvement with or without treatment (stroke, Parkinson's, dementia, multiple sclerosis, etc.). * Patients with inflammatory or autoimmune disease associated with Fibromyalgia. * Patients with infectious, neoplastic disease, or parenteral drug use. * Patients with insurmountable fear of needles * Under 18 years of age * Coagulation problems (including treatment with anticoagulants, due to the risk of bleeding). * Immunosuppressed people (due to the risk of infection), * Lymphadenectomized people (due to the risk of lymphedema) * Hypothyroidism (due to the risk of myxedema) * Pregnant patients * Patients with areas of the skin that present some type of wound, infection, macula or tattoo.
Source: ClinicalTrials.gov (US National Library of Medicine), snapshot October 2026. Check the registry for current recruiting status. Record: https://clinicaltrials.gov/study/NCT04942444